Codexis (CDXS) EBT Margin (2010 - 2026)

Codexis' (CDXS) quarterly EBT Margin came in at 56.85% in Q1 2026, up 21727.0% year-on-year from N/an in Q1 2025, and down 329.98% quarter-over-quarter from 24.72% in Q4 2025.

Codexis (CDXS) EBT Margin (2010 - 2026) Analysis & Trends

Codexis' EBT Margin history runs 17 years deep, the most recent figure standing at 56.85% for Q1 2026.

  • On a quarterly basis, EBT Margin rose 21727.0% year-over-year to 56.85% in Q1 2026; TTM through Mar 2026 was 40.87%, a 10853.0% increase from a year earlier, with the FY2025 full-year figure at 62.41%, up 4753.0% from the prior year.
  • EBT Margin declined to 56.85% in Q1 2026 per CDXS's latest filing, from 24.72% in the prior quarter.
  • Across five years, EBT Margin topped out at 24.72% in Q4 2025 and bottomed at 376.19% in Q3 2023.
  • The 5-year median for EBT Margin is 86.52% (2025), against an average of 131.06%.
  • Across the five-year window, EBT Margin plunged 34722 bps in 2023 and surged 21727 bps in 2026, its largest moves.
  • Year by year, EBT Margin stood at 62.89% in 2022, then sank by 128 bps to 143.14% in 2023, then jumped by 66 bps to 48.34% in 2024, then soared by 151 bps to 24.72% in 2025, then sank by 330 bps to 56.85% in 2026.
  • Per Business Quant, the three latest CDXS EBT Margin figures stand at 56.85% (Q1 2026), 24.72% (Q4 2025), and 227.96% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - -
2 Nanobiotix 1,908.96 Bn 1,908.90 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 474.03 Bn 469.24 Bn 1.35 Bn 17.13%
5 Vertex Pharmaceuticals 122.13 Bn 114.88 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 23.05%
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.96 Bn 50.77 Bn 1.41 Bn 34.77%
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 18.99%
10 Codexis 140.24 Mn 75.10 Mn 13.18 Mn -56.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -56.85%
Dec 31, 2025 24.72%
Sep 30, 2025 -227.96%
Jun 30, 2025 -86.52%
Mar 31, 2025 -274.12%
Dec 31, 2024 -48.34%
Sep 30, 2024 -160.76%
Jun 30, 2024 -285.06%
Mar 31, 2024 -67.33%
Dec 31, 2023 -143.14%
Sep 30, 2023 -376.19%
Jun 30, 2023 -230.28%
Mar 31, 2023 -174.09%
Dec 31, 2022 -62.89%
Sep 30, 2022 -28.96%
Jun 30, 2022 -6.59%
Mar 31, 2022 -23.62%
Dec 31, 2021 -41.31%
Sep 30, 2021 6.40%
Jun 30, 2021 -16.72%